Furthermore, intracellular LGALS3BP has a role in the prevention and treatment of inflammatory diseases by suppressing TAK1-dependent NF-κB activation [4] and regulates centriole biogenesis and centrosome hypertrophy in cancer cells [5]. Here, LGALS3BP is linked to cancer.